| Entry |
|
|---|
| Name |
Primidone;
5-Phenyl-5-ethyl-Hexahydropyrimidine-4,6-dione
|
|---|
| Formula |
C12H14N2O2
|
|---|
| Exact mass |
218.1055
|
|---|
| Mol weight |
218.25
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AA Barbiturates and derivatives
N03AA03 Primidone
D00474 Primidone (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Anticonvulsants
Gamma-aminobutyric Acid (GABA) Augmenting Agents
Barbituates
Primidone
D00474 Primidone (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
113 Antiepileptics
1135 Primidones
D00474 Primidone (JP18/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG01904 Barbiturate antiepileptic
D00474 Primidone
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03199 Antiepileptic agent
D00474 Primidone
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00474 Primidone
Prodrugs [br08324.html]
D00474
Prodrugs [br08324.html]
C07371
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 16
1 C1z C 22.4914 -18.6613
2 C8y C 23.6964 -17.9536
3 C5x C 21.2571 -17.9768
4 C5x C 22.4914 -20.0653
5 C1b C 23.6964 -19.3574
6 C8x C 24.9073 -18.6379
7 C8x C 23.7489 -16.5496
8 N1x N 20.0522 -18.6613
9 O5x O 21.2571 -16.5554
10 N1x N 21.2571 -20.7673
11 O5x O 23.6847 -20.7673
12 C1a C 25.0946 -19.3574
13 C8x C 26.1124 -17.9302
14 C8x C 24.8839 -15.8417
15 C1x C 20.0522 -20.0653
16 C8x C 26.1007 -16.5320
BOND 17
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 2
6 2 7 1
7 3 8 1
8 3 9 2
9 4 10 1
10 4 11 2
11 5 12 1
12 6 13 1
13 7 14 2
14 8 15 1
15 13 16 2
16 10 15 1
17 14 16 1
|
|---|
